
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues. In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Matt Argersinger discuss: How Nvidia continues to deliver in the face of great expectations, but even those great results haven…